Obesity and prostate cancer screening among African-American and Causian men

Prostate

Volumn 66, Issue 13, 2006, Pages 1371-1380

  Fowke, Jay H ^a,d   Signorello, Lisa B ^a,b   Underwood III, Willie ^a   Ukoli, Flora A M ^c   Blot, William J ^a,b  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^c MEHARRY MEDICAL COLLEGE   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Obesity; Prostate cancer; Race; Selection bias

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CANCER INCIDENCE; CANCER SCREENING; COMORBIDITY; EUROPEAN AMERICAN; HEART DISEASE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER; SOCIAL STATUS;

ADULT; AFRICAN AMERICANS; AGED; BODY MASS INDEX; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MASS SCREENING; MIDDLE AGED; OBESITY; ODDS RATIO; PATIENT SELECTION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; SELECTION BIAS; SOCIOECONOMIC FACTORS; SOUTHEASTERN UNITED STATES;

EID: 33748456478     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20377     Document Type: Article

References (39)

1. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. J Amer Med Assoc 2002;288(14):1723-1727.
2. Hsing AW. Hormones and prostate cancer: What next? Epidemiol Rev 2001;23(1):42-58.
3. Meier U, Gressner AM. Endocrine regulation of energy metabolism: Review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004;50(9):1511-1525.
4. Vendrell J, Broch M, Vilarrasa N, Molina A, Gomez JM, Gutierrez C, Simon I, Soler J, Richart C. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: Relationship to obesity. Obes Res 2004;12(6):962-971.
5. Stattin P, Bylund A, Rinaldi S, Biessy C, Dechaud H, Stenman UH, Egevad L, Riboli E, Hallmans G, Kaaks R. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: A prospective study. J Natl Cancer Inst 2000;92(23):1910-1917.
6. Hsing AW, Chua S, Gao Y-T, Gentzschein E, Chang L, Deng J, Stanczyk FZ. Prostate cancer risk and serum levels of insulin and leptin: A population based-study. JNCI 2001;93(10): 783-791.
7. Cerhan JR, Torner JC, Lyunch CF, Rubenstein LM, Lemke JH, Cohen MB, Lubaroff DM, Wallace RB. Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States). Cancer Causes Control 1997;8:229-238.
8. Chyou P-H, Nomura AMY, Stemmermann GN. A prospective study of weight, body mass index and other anthropometric measurements in relation to site-specific cancers. Int J Cancer 1994;57:313-317.
9. Rodriguez C, Patel AV, Calle EE, Jacobs EJ, Chao A, Thun MJ. Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev 2001;10:345-353.
10. Amling CL, Riffenburgh RH, Sun L, Moul JW, Lance RS, Kusuda L, Sexton WJ, Soderdahl DW, Donahue TF, Foley JP, Chung AK, McLeod DG. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 2004;22(3):439-445.
11. Freedland SJ, Aronson WJ, Kane CJ, Presti JC, Jr., Amling CL, Elashoff D, Terris MK. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: A report by the shared equal access regional cancer hospital database study group. J Clin Oncol 2004;22(3):446-453.
12. Andersson S-O, Wolk A, Bergstrom R, Adami H-O, Engholm G, Englund A, Nyren O. Body size and prostate cancer: A 20-year follow-up study among 135006 Swedish construction workers. JNCI 1997;89(5):385-389.
13. Hayes RB, Ziegler RG, Gridley G, Swanson C, Greenberg RS, Swanson GM, Schoenberg HB, Silverman DT, Brown LM, Pottern LM, Liff J, Schwartz AG, Fraumeni JF, Hoover RN. Dietary factors and risks for prostate cancer among Blacks and Whites in the United States. Cancer Epidemiol Biomarkers Prev 1999;8:25-34.
14. Snowdon D, Phillips R, Choi W. Diet. Obestiy and risk of fatal prostate cancer. Am J Epidemiol 1984;120(2):244-250.
15. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348(17):1625.
16. Severson RK, Grove JS, Nomura A, Stemmermann GN. Body mass and prostatic cancer: A prospective study. Br Med J 1988; 297:713-715.
17. LeMarchand L, Kolonel LN, Wilkins LR, Myers BC, Hirohata T. Animal fat consumption and prostate cancer: A prospective study in Hawaii. Epidemiology 1994;5:276-282.
18. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 1997;6:557-563.
19. Giovannucci E, Rimm EB, Liu Y, Leitzmann M, Wu K, Stampfer MJ, Willett WC. Body mass index and risk of prostate cancer in U.S. health professionals. JNCI Cancer Spectrum 2003;95(16): 1240-1244.
20. Whittemore AS, Paffenbarger RS, Anderson K, Lee JE. Early precursors of site-specific cancers in college men and women. JNCI 1985;74(1):43-51.
21. Mills PK, Beeson L, Phillips RL, Fraser GE. Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 1989;64: 598-604.
22. Porter MP, Stanford JL. Obesity and the risk of prostate cancer. The Prostate 2005;62:316-321.
23. Liu L, Cozen W, Bernstein L, Ross RK, Deapen D. Changing relationship between socioeconomic status and prostate cancer incidence. JNCI 2001;93(9):705-709.
24. Ernster VL, Selvin S, Sacks ST, Austin DF, Brown SM, Winkelstein W. Prostatic cancer: Mortality and incidence rates by race and social class. Am J Epidemiol 1978;107(4):311-320.
25. Schwartz KL, Crossley-May H, Vigneau FD, Brown K, Banerjee M. Race, socioeconomic status and stage at diagnosis for five common malignancies. Cancer Causes Control 2003;14(8):761-766.
26. Roetzheim RG, Pal N, Tennant C, Voti L, Ayanian JZ, Schwabe A, Krischer JP. Effects of health insurance and race on early detection of cancer. JNCI 1999;91(16):1409-1415.
27. Tingen MS, Weinrich S, Boyd M, Weinrich M. Demographic predictors of participation in prostate cancer screening. J Amer Acad Nurse Pract 1997;1:17-18.
28. Powell IJ, Schwartz K, Hussain M. Removal of the financial barrier to health care: Does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a veterans affairs system. Urology 1995;46(6):825-830.
29. Fontaine KR, Heo M, Allison DB. Obesity and prostate cancer screening in the USA. Public Health 2005;119(8):694-698.
30. Gilligan T, Wang PS, Levin R, Kantoff PW, Avorn J. Racial differences in screening for prostate cancer in the elderly. Arch Intern Med 2004;164(17):1858-1864.
31. Signorello LB, Hargreaves MK, Steinwandel MD, Zheng W, Cai Q, Schlundt DG, Buchowski MS, Arnold CW, McLaughlin JK, Blot WJ. Southern community cohort study: Establishing a cohort to investigate health disparities. J Natl Med Assoc 2005; 97(7):972-979.
32. Fowke JH, Schlundt D, Signorello LB, Ukoli FA, Blot WJ. Prostate cancer screening among low-income African-American and Caucasian men. Urol Oncol: Semin Orig Invest 2005;23(5):333-340.
33. Wee CC, McCarthy EP, Davis RB, Phillips RS. Screening for cervical and breast cancer: Is obesity an unrecognized barrier to preventive care? Ann Intern Med 2000;132(9):697-704.
34. Wee CC, McCarthy EP, Davis RB, Phillips RS. Obesity and breast cancer screening. J Gen Intern Med 2004;19(4):324-331.
35. Ross LE, Coates RJ, Breen N, Uhler RJ, Potosky AL, Blackman D. Prostate-specific antigen test use reported in the 2000 National Health Interview Survey. Prev Med 2004;38(6):732-744.
36. Chiu BCH, Anderson JR, Corbin D. Predictors of prostate cancer screening among health fair participants. Public Health 2005; 119(8):686-693.
37. Bosch JL, Hop WC, Bangma CH, Kirkels WJ, Schroder FH. Prostate specific antigen in a community-based sample of men without prostate cancer: Correlations with prostate volume, age, body mass index, and symptoms of prostatism. Prostate 1995;27(5):241-249.
38. Ku J, Kim ME, Lee NK, Park YH, Ahn JO. Influence of age, anthropometry, and hepatic and renal function on serum prostate-specific antigen levels in healthy middle-age men. Urology 2003;61(1):132-136.
39. Baillargeaon J, Pollock BH, Kristal AR, Bradshaw P, Hernandex J, Basler J, Higgins B, Lynch S, Rozanski T, Troyer D, Thompson I. The association of body mass index and prostate-specific antigen in a population-based study. Cancer 2005;103(March):1092-1095.